These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 24661438)
1. The barrier to HIV transmission provided by genital tract Lactobacillus colonization. Mirmonsef P; Spear GT Am J Reprod Immunol; 2014 Jun; 71(6):531-6. PubMed ID: 24661438 [TBL] [Abstract][Full Text] [Related]
2. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women. Reimers LL; Mehta SD; Massad LS; Burk RD; Xie X; Ravel J; Cohen MH; Palefsky JM; Weber KM; Xue X; Anastos K; Minkoff H; Atrio J; D'Souza G; Ye Q; Colie C; Zolnik CP; Spear GT; Strickler HD J Infect Dis; 2016 Nov; 214(9):1361-1369. PubMed ID: 27521363 [TBL] [Abstract][Full Text] [Related]
3. The Influence of Cervicovaginal Microbiota on Mucosal Immunity and Prophylaxis in the Battle against HIV. Farcasanu M; Kwon DS Curr HIV/AIDS Rep; 2018 Feb; 15(1):30-38. PubMed ID: 29516267 [TBL] [Abstract][Full Text] [Related]
4. Vaginal microbiota and its role in HIV transmission and infection. Petrova MI; van den Broek M; Balzarini J; Vanderleyden J; Lebeer S FEMS Microbiol Rev; 2013 Sep; 37(5):762-92. PubMed ID: 23789590 [TBL] [Abstract][Full Text] [Related]
5. Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women. Borgdorff H; Tsivtsivadze E; Verhelst R; Marzorati M; Jurriaans S; Ndayisaba GF; Schuren FH; van de Wijgert JH ISME J; 2014 Sep; 8(9):1781-93. PubMed ID: 24599071 [TBL] [Abstract][Full Text] [Related]
6. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis. Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984 [TBL] [Abstract][Full Text] [Related]
7. Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology. Shannon B; Gajer P; Yi TJ; Ma B; Humphrys MS; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Shahabi K; Ravel J; Kaul R J Infect Dis; 2017 May; 215(9):1366-1375. PubMed ID: 28201724 [TBL] [Abstract][Full Text] [Related]
8. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. Doerflinger SY; Throop AL; Herbst-Kralovetz MM J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560 [TBL] [Abstract][Full Text] [Related]
9. Exploratory comparison of vaginal glycogen and Lactobacillus levels in premenopausal and postmenopausal women. Mirmonsef P; Modur S; Burgad D; Gilbert D; Golub ET; French AL; McCotter K; Landay AL; Spear GT Menopause; 2015 Jul; 22(7):702-9. PubMed ID: 25535963 [TBL] [Abstract][Full Text] [Related]
10. Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pH. Mirmonsef P; Hotton AL; Gilbert D; Burgad D; Landay A; Weber KM; Cohen M; Ravel J; Spear GT PLoS One; 2014; 9(7):e102467. PubMed ID: 25033265 [TBL] [Abstract][Full Text] [Related]
11. Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women. Gosmann C; Anahtar MN; Handley SA; Farcasanu M; Abu-Ali G; Bowman BA; Padavattan N; Desai C; Droit L; Moodley A; Dong M; Chen Y; Ismail N; Ndung'u T; Ghebremichael MS; Wesemann DR; Mitchell C; Dong KL; Huttenhower C; Walker BD; Virgin HW; Kwon DS Immunity; 2017 Jan; 46(1):29-37. PubMed ID: 28087240 [TBL] [Abstract][Full Text] [Related]
12. The human vaginal microbial community. Vaneechoutte M Res Microbiol; 2017; 168(9-10):811-825. PubMed ID: 28851670 [TBL] [Abstract][Full Text] [Related]
13. gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmission. Stoddard E; Cannon G; Ni H; Karikó K; Capodici J; Malamud D; Weissman D J Immunol; 2007 Sep; 179(5):3126-32. PubMed ID: 17709527 [TBL] [Abstract][Full Text] [Related]
14. Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV. Cone RA J Infect Dis; 2014 Dec; 210 Suppl 3(Suppl 3):S616-21. PubMed ID: 25414415 [TBL] [Abstract][Full Text] [Related]
15. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility. Mohammadi A; Bagherichimeh S; Perry MC; Fazel A; Tevlin E; Huibner S; Tharao W; Coburn B; Kaul R Sci Rep; 2020 May; 10(1):8514. PubMed ID: 32444843 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense. Cole AM; Cole AL Am J Reprod Immunol; 2008 Jan; 59(1):27-34. PubMed ID: 18154593 [TBL] [Abstract][Full Text] [Related]
17. Effect of pH on Cleavage of Glycogen by Vaginal Enzymes. Spear GT; McKenna M; Landay AL; Makinde H; Hamaker B; French AL; Lee BH PLoS One; 2015; 10(7):e0132646. PubMed ID: 26171967 [TBL] [Abstract][Full Text] [Related]
18. Human α-amylase present in lower-genital-tract mucosal fluid processes glycogen to support vaginal colonization by Lactobacillus. Spear GT; French AL; Gilbert D; Zariffard MR; Mirmonsef P; Sullivan TH; Spear WW; Landay A; Micci S; Lee BH; Hamaker BR J Infect Dis; 2014 Oct; 210(7):1019-28. PubMed ID: 24737800 [TBL] [Abstract][Full Text] [Related]
19. Role of semen in modulating the female genital tract microenvironment--implications for HIV transmission. Doncel GF; Anderson S; Zalenskaya I Am J Reprod Immunol; 2014 Jun; 71(6):564-74. PubMed ID: 24702729 [TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. Lai SK; Hida K; Shukair S; Wang YY; Figueiredo A; Cone R; Hope TJ; Hanes J J Virol; 2009 Nov; 83(21):11196-200. PubMed ID: 19692470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]